Rajesh Marwaha
Corporate Officer/Principal chez The Institute of Chartered Accountants of India
Profil
Rajesh Marwaha is a Member of The Institute of Chartered Accountants of India and currently holds a position there.
He was previously the Chief Financial Officer & Executive Director at AstraZeneca Pharma India Ltd.
from 2016 to 2023 and the Chief Financial Officer & Head-Investor Relations at Fulford (India) Ltd.
in 2013.
He also worked as a Controller-Sales & Commercial Division at Groupe Seb SA (United Arab Emirates).
Postes actifs de Rajesh Marwaha
| Sociétés | Poste | Début |
|---|---|---|
| The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
Anciens postes connus de Rajesh Marwaha
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PHARMA INDIA LIMITED | Director of Finance/CFO | 30/09/2023 |
| FULFORD (INDIA) LIMITED | Director of Finance/CFO | 02/08/2013 |
| Groupe Seb SA (United Arab Emirates) | Sales & Marketing | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASTRAZENECA PHARMA INDIA LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
| Groupe Seb SA (United Arab Emirates) |
